Steve Cosgrove

Title: Steve Cosgrove: Innovator in Chemical Compounds

Introduction

Steve Cosgrove is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of chemistry, particularly in the development of new forms of chemical compounds. His work has implications for pharmaceutical applications, showcasing the intersection of innovation and healthcare.

Latest Patents

Steve Cosgrove holds a patent for the crystalline and amorphous form of a triazolo (4,5-D) pyrimidine compound. This invention provides new forms of a chemical compound of formula (I). It specifically relates to four crystalline forms and an amorphous form. The invention also includes processes for the preparation of these forms, pharmaceutical compositions comprising the compound, and therapeutic uses of such forms.

Career Highlights

Steve Cosgrove is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to advancements in drug development and chemical research. His innovative approach has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Steve has collaborated with notable colleagues, including Martin Hans Bohlin and Bo Lassen. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Steve Cosgrove's contributions to the field of chemical compounds exemplify the importance of innovation in pharmaceuticals. His patent and work at AstraZeneca highlight his role in advancing healthcare solutions.